Sign in

CIK 0001231457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −80,000 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −13,333 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +13,333 13,333
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −65,000 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2025-08-27 Tyree James L Director Grant or award +22,283 68,074
2025-08-27 Tyree James L Director Grant or award · Stock Option (Right to Buy) +28,576 28,576
2025-08-27 Smither John W Director Grant or award +22,283 74,994
2025-08-27 Smither John W Director Grant or award · Stock Option (Right to Buy) +28,576 28,576
2025-08-27 Mirabelli Mary Director Grant or award +22,283 73,284
2025-08-27 Mirabelli Mary Director Grant or award · Stock Option (Right to Buy) +28,576 28,576
2025-08-27 Thomas John Director Grant or award +22,283 502,784
2025-08-27 Thomas John Director Grant or award · Stock Option (Right to Buy) +28,576 28,576
2025-08-27 Zindrick Thomas President and CEO Grant or award +361,200 554,161
2025-08-27 Zindrick Thomas President and CEO Grant or award · Stock Option (Right to Buy) +478,800 478,800
2025-08-27 Yu Yong SVP, Clinical Development Grant or award +101,480 150,036
2025-08-27 Yu Yong SVP, Clinical Development Grant or award · Stock Option (Right to Buy) +134,520 134,520
2025-08-27 Smalling Ralph Head of Regulatory Grant or award +26,230 60,990
2025-08-27 Smalling Ralph Head of Regulatory Grant or award · Stock Option (Right to Buy) +34,770 34,770

Page 4 of 9 · 170 trades